Dexcom | DXCM - Cost Of Sales


Dexcom reported $478.4M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Align Technology USD 298.76M 4.74M Jun/2026
AtriCure USD 34.98M 3.04M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cooper Companies USD 393.8M 17M Mar/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
J&J USD 8B 67M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Solventum Corp USD 923M 12M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
West Pharmaceutical Services USD 543.1M 5.4M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026